Ditte Rudå

发表

Measuring movements in adolescents with psychosis using the Microsoft Kinect sensor: a pilot study exploring a new tool for assessing aspects of antipsychotic-induced parkinsonism.

Jannik Boll Matthiassen, C. Correll, A. Fink-Jensen, 2020, Child and adolescent mental health.

CYP2D6 Genotyping and Antipsychotic-Associated Extrapyramidal Adverse Effects in a Randomized Trial of Aripiprazole Versus Quetiapine Extended Release in Children and Adolescents, Aged 12–17 Years, With First Episode Psychosis

T. Werge, C. Correll, A. Fink-Jensen, 2021, Journal of clinical psychopharmacology.

Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12–43 years

E. Rostrup, C. Pantelis, C. Correll, 2020, Psychological Medicine.

Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial

T. Werge, J. Pedersen, C. Correll, 2014, BMC Psychiatry.

Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial.

C. Correll, A. Fink-Jensen, B. Fagerlund, 2019, Journal of the American Academy of Child and Adolescent Psychiatry.

Early Antipsychotic Non-response as a Predictor of Non-response and Non-remission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA Trial.

C. Correll, A. Fink-Jensen, B. Fagerlund, 2022, Journal of the American Academy of Child and Adolescent Psychiatry.

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.

T. Werge, C. Correll, A. Fink-Jensen, 2017, The lancet. Psychiatry.

Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.

C. Correll, A. Fink-Jensen, B. Fagerlund, 2017, The Journal of clinical psychiatry.

Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial

C. Correll, A. Fink-Jensen, B. Fagerlund, 2018, Psychopharmacology.

Computer Aided Identification of Motion Disturbances Related to Parkinson's Disease

Jannik Boll Nielsen, Rasmus R. Paulsen, Line Harder Clemmensen, 2018, PRIME@MICCAI.

Exploring Movement Impairments in Patients With Parkinson's Disease Using the Microsoft Kinect Sensor: A Feasibility Study

Jannik Boll Matthiassen, C. Correll, A. Fink-Jensen, 2021, Frontiers in Neurology.